ESR1 and breast cancer: A different clinical class of pharmaceuticals is Tamoxifen, a selective estrogen receptor modulator (SERM) that blocks estrogen action by binding to the estrogen receptor (ER) in breast cancer and has been widely used during the last 30 years for the treatment of breast cancer [334].